Zydus Cadila gets EIR from US FDA for Ankleshwar facility Press Trust of India Sep 23, 2019 The EIR report stated that the classification of the facility is "No Action Indicated (NAI)", the company added
Sanofi India to sell Ankleshwar site to Zentiva EP News Bureau Sep 11, 2019 Board of Directors approve slump sale and transfer of the manufacturing facility The Board of Directors of Sanofi India has…
Cadila Pharma celebrates World Day for Safety and Health at Work Usha Sharma Apr 28, 2015 Activities conducted at Bhat, Dholka, Ankleshwar, Kadi and Hirapur locations to commemorate International Labour Organisation
